Translational research provides a much needed bridge of communication between highly specialized research scientists and physicians. Researchers working in labs with microscopes and tissue samples and physicians who directly interact with patients speak very different languages. It is vital that cutting edge research arrives to physicians in a useable format. It is also essential that information gathered from physicians get to researchers.
The translational process involves identifying current significant research projects and taking the knowledge and learning of these studies and applying it directly to the patient level. Fundamentally, it puts valuable theories into practice - a progression absolutely necessary in finding a cure.
Translational research is central to the research strategy of the London Regional Cancer Program (LRCP). Our research program is linked to the University of Western Ontario and the London Health Sciences Centre research community, and is multi-disciplinary and multi-departmental.
History of the Unit
The Pamela Greenaway-Kohlmeier Translational Breast Cancer Unit was named for Pamela Greenaway-Kohlmeier, daughter of Lawrence and Kay Greenaway and wife of Guy Kohlmeier. Pamela died of breast cancer at age 38, which led her family to form the Breast Cancer Society of Canada (BCSC) to raise funds for breast cancer research.
The Unit was created in 1998, through a partnership between the London Regional Cancer Program (LRCP) and a $1 million donation from the Breast Cancer Society of Canada to the LRCP. The partnership between the BCSC and LRCP has flourished since then. The BCSC renewed its commitment to the Unit in 2004 and again in 2009, providing over $5.2 million to support our work.
In 2014 the BCSC announced a further 10 year, $5 million commitment to the Unit, bringing BCSC support to the Unit to $10.2 million.
About this new donation, Marsha Davidson, Executive Director of the BCSC, said “This gift represents the largest funding commitment ever made in our 23-year history. We are proud to fund our partners at London Health Sciences Centre and the Translational Breast Cancer Research Unit - more than $10 million cumulatively - to continue the TBCRU’s world-renowned, life-saving research.”
In thanking the BCSC for this remarkable new commitment, Unit Director Ann Chambers said “I thank the Breast Cancer Society of Canada for sharing our vision and helping us to create programs in London that are focused on improving diagnosis and care of breast cancer patients. We are grateful for this remarkable, ongoing support.”
This gift was celebrated on September 10, 2014.
Other community groups have joined in supporting the Unit, including Alan Frew and the Rose in My Book group, Theresa Carriere and her OneRun team, the Southwestern Ontario Women's Charity Cashspiel, Fore the Cure, Strokes for Cancer, the Belmont Golf Tournament and many others. We are grateful for such strong community support for our Unit.
We would be delighted if you also want to support our Unit.
A major goal of the Translational Breast Cancer Research Unit is to encourage and support trainees who are carrying out translational breast cancer research. By encouraging bright trainees to focus their research attention in this area, we hope to increase the number of highly qualified researchers who are working to solve the problem of breast cancer. You can read about some of the research being carried out by these talented young researchers on the BCSC Pink Link blog page.
Call for Applicants
APPLICATION DEADLINE: Monday July 13, 2020
Recipients of Translational Breast Cancer Research Traineeship Program: Studentships
Translational Breast Cancer Research Unit:
Dr. Alison Allan, Director by e-mail, or telephone at 519.685.8600 x 55134